Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Laboratory services group SourceBio International warned that changing rules around Covid-19 testing for travellers would limit its annual earnings growth.
The UK government said day-two and day-eight testing requirements for travellers would be removed in October for fully vaccinated individuals from low-risk countries.
SourceBio said its still expected full-year revenue and adjusted earnings to show 'dramatic' growth.
'However the changes to travel PCR testing are expected to impact on the level of this expected material growth,' it added.
'The company is evaluating the full year 2021 and 2022 and will provide a full trading update as part of its interim results Statement which is scheduled to be released on 28 September 2021.'